David J. Schlanger - Feb 2, 2023 Form 4 Insider Report for Progyny, Inc. (PGNY)

Signature
/s/ Mark Livingston, Attorney-in-Fact
Stock symbol
PGNY
Transactions as of
Feb 2, 2023
Transactions value $
-$7,010,472
Form type
4
Date filed
2/6/2023, 04:02 PM
Previous filing
Feb 2, 2023
Next filing
Feb 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PGNY Common Stock Options Exercise $91K +100K +131.29% $0.91* 176K Feb 2, 2023 Direct
transaction PGNY Common Stock Sale -$2.21M -61K -34.65% $36.12 115K Feb 2, 2023 Direct F1, F2
transaction PGNY Common Stock Sale -$1.43M -39K -33.84% $36.79 76.2K Feb 2, 2023 Direct F1, F3
transaction PGNY Common Stock Options Exercise $91K +100K +131.29% $0.91* 176K Feb 3, 2023 Direct
transaction PGNY Common Stock Sale -$3.36M -94.6K -53.72% $35.51 81.5K Feb 3, 2023 Direct F1, F4
transaction PGNY Common Stock Sale -$194K -5.36K -6.57% $36.14 76.2K Feb 3, 2023 Direct F1, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PGNY Stock Option (Right to Buy) Options Exercise $0 -100K -8.84% $0.00 1.03M Feb 2, 2023 Common Stock 100K $0.91 Direct F6, F7
transaction PGNY Stock Option (Right to Buy) Options Exercise $0 -100K -9.7% $0.00 931K Feb 3, 2023 Common Stock 100K $0.91 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.46 to $36.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.47 to $37.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.04 to $36.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.05 to $36.51, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 These options are fully vested and exercisable.
F7 The amount reported in Column 9 of Table II reflects the Reporting Person's stock option exercise of 1,452 options, which were previously inadvertently omitted, as disclosed in the Reporting Person's Form 4/A filed on February 6, 2023.